Center Book Partners LP Ligand Pharmaceuticals Inc Transaction History
Center Book Partners LP
- $1.54 Billion
- Q3 2024
A detailed history of Center Book Partners LP transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Center Book Partners LP holds 50,976 shares of LGND stock, worth $6.25 Million. This represents 0.33% of its overall portfolio holdings.
Number of Shares
50,976
Previous 53,379
4.5%
Holding current value
$6.25 Million
Previous $4.5 Million
13.54%
% of portfolio
0.33%
Previous 0.3%
Shares
3 transactions
Others Institutions Holding LGND
# of Institutions
257Shares Held
18.2MCall Options Held
26.8KPut Options Held
9.3K-
Black Rock Inc. New York, NY2.87MShares$352 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.97MShares$242 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.01MShares$124 Million0.05% of portfolio
-
Macquarie Group LTD Australia, C3887KShares$109 Million0.1% of portfolio
-
State Street Corp Boston, MA707KShares$86.8 Million0.0% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $2.07B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...